Notice of Corporate Officer Changes
September 11, 2025, Osaka, Japan – Santen Pharmaceutical Co., Ltd. today announces Corporate Officer appointments that will be taking effect from October 1, 2025.
Corporate Officer Appointments Effective October 1, 2025
| Name | New Position | Current Position |
|---|---|---|
| Ippei Kurihara* | Director of the Board Corporate Officer Head of Japan Business, Business Development | Director of the Board Corporate Officer Head of Japan Business, Global Commercial Strategy |
| Mika Masunari* | Corporate Officer General Counsel, Chief Compliance Officer & Chief Risk Officer | Corporate Officer General Counsel & Chief Compliance Officer |
| Tomohisa Watanabe* (Newly appointed) | Corporate Officer Global Head of Corporate Strategy | Head of Global Portfolio & Commercial Excellence |
| Yoko Saiki* | Corporate Officer Chief Human Resources Officer | Corporate Officer Global Head of Corporate Strategy |
*All of the above Corporate Officers are Corporate Management Members (CMM).
About Santen
As a specialized company dedicated to eye health, Santen aspires to contribute to the realization of “Happiness with Vision” by providing products and services to patients, consumers, and medical professionals around the world. Since its establishment, and guided by its CORE PRINCIPLE, “Tenki ni sanyo suru,” Santen has been committed to helping people maintain and improve their eye health for more than 130 years. Santen is engaged in the global research and development, manufacturing, and sales and marketing of pharmaceutical products in the field of eye care, supporting the eye health of approximately 50 million people in more than 60 countries and regions worldwide. Santen’s mission is to provide essential and significant value to patients and society in the prevention, diagnosis, and treatment of eye diseases through products and services created from its expertise in the ophthalmology field and from the patient's perspective. To create a future in which as many patients as possible can lead happy and fulfilling lives, Santen is committed to doing its utmost to realize a society in which people around the world can experience “Happiness with Vision.”
For more information, please visit Santen’s website https://www.santen.com/en.
Contact
Corporate Communications
Santen Pharmaceutical Co., Ltd.
E-mail: communication@santen.com
Official SNS
